Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
December 14, 2024 16:54 ET | Source: Kellner Group Vote “FOR” All…
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions…
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”)…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
December 14, 2024 16:54 ET | Source: Kellner Group Vote “FOR” All…
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions…
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”)…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
